4:06 PM ET
10-Q
Financial Results
Avenue Therapeutics Q3 2026 Results: Net Loss of $691K, Loss Widens
Avenue Therapeutics reported a net loss of $2.1 million for the nine months ended September 30, 2026, compared to $2.2 million in the prior year period. The company currently generates no revenue and has expressed substantial doubt about its ability to continue as a going concern due to an accumulated deficit of $107.6 million and limited cash reserves of $1.5 million.
- Key figure
- Net loss $691K